Primary Trabeculectomy with Mitomycin C for Medically Uncontrolled Angle Closure Glaucoma.
- Author:
Jin Sook YOON
1
;
Chan Yoon KIM
;
Young Jae HONG
Author Information
1. The Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea. yjhong0815@yumc.yonsei.ac.kr
- Publication Type:Original Article
- Keywords:
Angle-closure glaucoma;
Complication;
Intraocular pressure;
Mitomycin C;
Trabeculectomy
- MeSH:
Follow-Up Studies;
Glaucoma, Angle-Closure*;
Humans;
Intraocular Pressure;
Mitomycin*;
Postoperative Complications;
Retrospective Studies;
Trabeculectomy*
- From:Journal of the Korean Ophthalmological Society
2004;45(5):783-789
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To report the results of primary trabeculectomy with mitomycinmitomycin C (MMC) for medically uncontrolled, primary angle-closure glaucoma. METHODS: A retrospective study of 20 eyes from 18 consecutive patients with medically uncontrolled primary angle-closure glaucoma who underwent trabeculectomy with MMC, from 1997 to 2000. RESULTS: The mean follow up was 33.9 +/- 12.9 months (range 24~60). After trabeculectomy with MMC, IOP remained below 22 mmHg in 17 eyes (85%) with or without medication. Postoperative complications occurred in 5 eyes (25%). CONCLUSIONS: Trabeculectomy with MMC resulted in favorable long-term IOP control and relatively low complications in medically unresponsive acute angle-closure glaucoma.
